Status: current, Defined. Date: 31-Dec 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4503621000168110 | hyaluronate sodium 30 mg / 1 mL + sodium chondroitin sulfate 40 mg / 1 mL intraocular injection, 1 x 0.5 mL syringe (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4503631000168113 | sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | has MPUU | sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe | true | Inferred relationship | Some | 1778920975 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Viscoat intraocular injection, 0.5 mL syringe | Is a | True | sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, 0.5 mL syringe | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR